Nasopharyngeal lymphomas: Further evidence for a natural killer cell origin

Human Pathology

Volumn 27, Issue 8, 1996, Pages 827-833

  Petrella, Tony ^a   Delfau Larue, Marie Helene ^b   Caillot, Denis ^b   Morcillo, Jean Louis ^b   Casasnovas, Olivier ^b   Portier, Henri ^b   Gaulard, Philippe ^b   Farcet, Jean Pierre ^b   Arnould, Laurent ^b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b NONE

Author keywords

Epstein Barr virus; lethal midline granuloma; nasopharyngeal lymphoma; natural killer cells

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CASE REPORT; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NASOPHARYNX TUMOR; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA PROBE; SOUTHERN BLOTTING; T CELL LYMPHOMA; TUMOR DIAGNOSIS;

EID: 0029796207     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90457-8     Document Type: Article

References (52)

1. Ferry JA, Sklar J, Zukerberg LR, et al: Nasal lymphoma: A clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol 15:268-279, 1991
2. Chan JKC, Ng CS, Lau WH, et al: Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 11:418-429, 1987
3. Lippman SM, Grogan T, Spier C, et al: Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma. Cancer 59:936-939, 1987
4. Gaulard P, Henni T, Marrolleau JP, et al: Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis: Evidence for a monoclonal T-cell disorder. Cancer 62:705-710, 1988
5. Cabane J, Raphael M, Lamas G, et al: Origin of malignant centrofascial granulomas: Surface markers and gene rearrangement of malignant cells. Laryngoscope 101:998-1001, 1991
6. Van Gorp J, De Bruin PC, Sie-Go DMDS, et al: Nasal T-cell lymphoma: A clinicopathological and immunophenotypic analysis of 13 cases. Histopathology 27:139-148, 1995
7. Chott A, Rappersberger K, Schlossarek W, et al: Peripheral T cell lymphoma presenting primarily as lethal midline granuloma. HUM PATHOL 19:1093-1103, 1988
8. Van Gorp J, Weiping L, Yong-Huei L, et al: Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western China. J Pathol 173:81-87, 1994
9. Ng CS, Chan JCK, Lo STH, et al: Expression of natural killer cell markers in non-Hodgkin's lymphomas. HUM PATHOL 18:1257-1262, 1987
10. Aozasa K, Oshawa M, Tajima K, et al: Nation-wide study of lethal mid-line granuloma in Japan: Frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer 44:63-66, 1989
11. Wong KF, Chan JKC, Ng CS, et al: CD56 (NKH1)-positive malignancies: An aggressive neoplasm featuring frequent cutaneous/ mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. HUM PATHOL 23:798-804, 1992
12. Kanavaros P, Lese MC, BriereJ, et al: Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 81:2688-2695, 1993
13. Suzumiya J, Takeshita M, Kimura N, et al: Expression of adult and fetal natural cell killer markers in sinonasal lymphomas. Blood 83:2255-2260, 1994
14. Kaneko T, Fukada J, Yoshihara T, et al: Nasal natural killer (NK) cell lymphoma: Report of a case with actived NK cells containing Epstein-Barr virus expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells. Br J Haematol 91:355-361, 1995
15. Chan JKC, Ng CS, Tsang WYW: Nasal/nasopharyngeal lymphomas: An immunohistochemical analysis of 57 cases on frozen tissues. Mod Pathol 6:87A, 1993 (abstr)
16. Harabuchi Y, Yamanaka N, Kataura A, et al: Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335:128-130, 1990
17. Weiss LM, Gaffey MJ, Chen YY, et al: Frequency of Epstein-Barr viral DNA in "Western" sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am J Surg Pathol 16:156-162, 1992
18. Medeiros LJ, Jaffe ES, Chen W, et al: Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am J Surg Pathol 16:439-447, 1992
19. Luzi P, Leoncini L, Funto I, et al: Epstein-Barr virus infection in sinonasal non-Hodgkin's lymphomas, Virchows Arch 425:121-125, 1994
20. Chan JCK, Yip TTC, Tsang WYW, et al: Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 18:938-946, 1994
21. Arber DA, Weiss LM, Albujar PF, et al: Nasal lymphomas in Peru: High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 17:392-399, 1993
22. Mishima K, Horiuchi K, Kojya S, et al: Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan. Cancer 73:3041-3046, 1994
23. Strickler J, Meneses MF, Habermann TM, et al: Polymorphic reticulosis: A reappraisal. HUM PATHOL 25:659-665, 1994
24. Ho FCS, Srivastava G, Loke SL, et al: Presence of Epstein-Barr virus DNA in nasal lymphomas of B and T cell type. Hematol Oncol 8:271-281, 1990
25. Borisch B, Hennig I, Laeng RH, et al: Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood 82:858-864, 1993
26. The non-Hodgkin's lymphoma pathologic classification project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
27. Stansfeld AG, Diebold J, Noel H, et al: Updated Kiel classification for lymphomas. Lancet 1:292-293, 1988
28. Theodorou I, Delfau-Larue MH, Bigorgne C, et al: Cutaneous T-cell infiltrates: Analysis of TCR ãgene by PCR and denaturing gradient gel electrophoresis. Blood 86:305-310, 1995
29. Theodorou I, Bigorgne C, Delfau MH, et al: VJ rearrangements of the TCR ãlocus in peripheral T cell lymphomas: Analysis by polymerase chain reaction and denaturing gradient gel electrophoresis. J Pathol 178:303-308, 1996
30. Wood GS, Tung RM, Haeffner AC, et al: Detection of clonal T-cell receptor γ gene rearrangements in early mycosis fungoides/ Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 41:34-41, 1994
31. Greiner TC, Raffeid CL, Dick F, et al: Analysis of T cell receptor-γ gene rearrangements by denaturing gradient gel electrophoresis of GC-clamped polymerase chain reaction products: Correlation with tumor-specific sequences. Am J Pathol 146:46-55, 1995
32. Longo MC, Berninger MS, Harley JL: The use of Uracil DNA glycosylase to control carryover contamination in polymerase chain reactions. Gene 93:125-128, 1990
33. Myers RM, Maniatis T, Lerman L: Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol 155:501-527, 1987
34. Kanavaros P, Farcet JP, Gaulard P, et al: Recombination events of the T cell antigen receptor g gene in the peripheral T cell lymphomas. J Clin Invest 87:666-672, 1991
35. Theodorou I, Raphael M, Bigorgne C, et al: Recombinative pattern of the TCRγ locus in human peripheral T cell lymphomas. J Pathol 174:233-242, 1994
36. Anderson P, Nagler-Anderson C, O'Brien C, et al: A monoclonal antibody reactive with a 15-kD cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol 144:574-582, 1990
37. Kawakami A, Tian Q, Duan X, et al: Identification and functional characterization of a TIA-1-related nucleolysin. Proc Natl Acad Sci U S A 89:8681-8685, 1992
38. Ho FCH, Choy D, Loke SL, et al: Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: A clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. HUM PATHOL 21:1041-1050, 1990
39. Robertson MJ, Ritz J: Biology and clinical relevance of natural killer cells. Blood 76:2421-2438, 1990
40. Lanier LL, Chang C, Spits H, et al: Expression of cytoplasmic CD3∈ proteins in activated human adult natural killer (NK) cells and CD3γ,δ,∈ complexes in fetal NK cells: Implications for the relationship of NK and T lymphocytes. J Immunol 149:1876-1880, 1992
41. Salmeron A, Sanchez-Madrid F, Ursa MA, et al: A conformational epitope expressed upon association of CD3-∈ with either CD3-δ or CD3-γ is the main target for recognition by anti-CD3 monoclonal antibobies. J Immunol 147:3047-3052, 1991
42. Soler J, Bordes R, Ortuno F, et al: Aggressive natural killer cell leukaemia/lymphoma in two patients with lethal midline granuloma. Br J Heamatol 86:659-662, 1994
43. Ye YL, Zhou Mh, Lu Xy, et al: Nasopharyngeal and nasal malignant lymphoma: A clinicopathological study of 54 cases. Histopathology 20:511-516, 1992
44. Suzumiya J, Takeshita M, Kimura N, et al: Sinonasal malignant lymphoma of natural killer cell phenotype associated with diffuse pancreatic involvement. Leuk Lymph 10:231-236, 1993
45. Tsang WYW, Chan JKC, Yip TTC, et al: In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas. HUM PATHOL 25:758-765, 1994
46. Kern WF, Spier CM, Hanneman EH, et al: Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A variant with a propensity for unusual sites involvement. Blood 79:2432-2437, 1992
47. Kanavaros P, de Bruin PC, Briere J, et al: Epstein-Barr virus (EBV) in extra-nodal non-Hodgin's lymphomas (T-NHL): Identification of nasal T-cell as a distinct clinicopathological entity associated with EBV. Leuk Lymph 18:27-34, 1995
48. Kanavaros P, Briere J, Lescs MC, et al: Epstein-Barr Virus in non-Hodgkin's lymphomas of the upper respiratory tract: Association with sinonasal localisation and expression of NK and/or T-cell antigens by tumor cells. J Pathol 178:297-302, 1996
49. De Bruin PC, Jiwa NM, Van der Valk P, et al: Detection of Epstein Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: Relation between latent membrane protein-1 positivity and clinical course. Histopathology 23:509-513, 1993
50. Wang D, Liebowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840, 1985
51. Henderson S, Rowe M, Gregory C, et al: Induction of bc12 expression by Epstein-Barr virus latent membrane protein 1 protects infected cells from programmed cell death. Cell 65:1107-1115, 1991
52. Wong KF, Chan JKC: CD56 (NCAM)-positive malignant lymphoma. Leuk Lymph 14:29-36, 1994